Molecular screening of the CFTR gene in men with anomalies of the vas deferens: Identification of three novel mutations

32Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Many studies have shown that congenital absence of the vas deferens (CAVD) is a genital cystic fibrosis transmembrane conductance regulator (CFTR)-mediated phenotype, with a broad spectrum of abnormalities causing male infertility. The genotype of these patients includes mutations in the CFTR gene, e.g. ΔF508, R117H and the T5 allele; all of which are commonly found in CAVD. In this study we have screened the entirety of CFTR gene in 47 males with anomalies of the vas deferens: 37 cases of congenital bilateral absence of the vas deferens, three cases of congenital unilateral absence of the vas deferens and seven cases of obstructive azoospermia with hypoplastic vas deferens. Among the 94 chromosomes studied, 65 mutations, of which three are novel (2789 + 2insA, L1227S, 4428insGA), were identified. The majority of patients (63.8%) had two detectable CFTR gene mutations. Furthermore, high frequencies of the ΔF508 mutation (44.7%), the T5 allele (36.2%) and R117H mutation (19.1%) were observed.

Cite

CITATION STYLE

APA

Jézéquel, P., Dubourg, C., Le Lannou, D., Odent, S., Le Gall, J. Y., Blayau, M., … David, V. (2000). Molecular screening of the CFTR gene in men with anomalies of the vas deferens: Identification of three novel mutations. Molecular Human Reproduction, 6(12), 1063–1067. https://doi.org/10.1093/molehr/6.12.1063

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free